Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 128 results for "orchid pharma"

Cipla, Divis Labs, Glenmark to get astro support: Gupta

Pharma stocks like Strides Arcolab, Divis Laboratories, Glenmark Pharma, Dishman Pharma, Orchid Chemicals and Cipla will get astro support, says Satish Gupta of astrostocktips. Money Control, 1 month ago
Pharma shares dip on profit bookings Business Standard India, 1 month ago

SBI appoints its former deputy MD as nominee on Orchid Pharma board

Nomination part of Corporate Debt Restructuring BS Reporter | Chennai March 30, 2015 Last Updated at 15:44 IST State Bank of India (SBI) has nominated former deputy managing director Soundara Kumar as its nominee on the Board of the Orchid Chemicals & ...
 Business Standard1 month ago

Orchid Chemicals' net loss widens to Rs 120 crore in December quarter

Pharma firm Orchid Chemicals today said its net loss widened to Rs 120.09 crore for the quarter ended December 31, 2014. The company had reported a net loss of Rs 53.90 crore for the same period of previous fiscal. Net sales of the company declined to Rs ...
 Economic Times2 months ago
Sify

Sensex stages modest recovery after falling 230 pts; Pharma stocks down sharply

Despite positive global cues, the Indian stock market has slipped deeper into the red after a somewhat listless start this morning, amid continued worries about falling earnings of India Inc. According to data available, foreign investors were net ...
 Sify1 week ago

Will Indian pharma buckle under regulations?

Posted by Equitymaster Indian pharma companies have been facing the heat from a stringent US Food and Drug Administration (USFDA). As a majority of domestic generic companies derive a lion's share of revenues from the US market, the largest number of ...
 Equitymaster.com1 week ago Performances of top 25 Indian pharma cos in 9 months indicate 2014-15 a tough year  PharmaBiz4 weeks ago

India Pharma Outlook 2015: Accelerating Growth to the Next Level: Moving Up the Value Chain Beyond Generics, New Report Launched

Market Research Reports, Inc. has announced the addition of India Pharma Outlook 2015: Accelerating growth to the next level: Moving up the value chain beyond Genericsresearch report to their website http://www.MarketResearchReports.com Lewes, DE ...
 Digital Journal2 months ago Market Research Reports, Inc. (www.marketresearchreports.com): India Pharma Outlook 2015: Accelerating growth to the next level: Moving up the value chain beyond Generics, New Report Launched  BusinessWeek2 months ago Research and Markets: India Pharma Outlook 2015: Accelerating Growth to the Next Level - Moving Up the Value Chain Beyond Generics  Pharmacy Choice1 month ago RESEARCH AND MARKETS : India Pharma Outlook 2015: Accelerating Growth to the Next Level - Moving Up the Value Chain Beyond Generics  4 Traders1 month ago
[x]  

Pharmaceutical Contract Manufacturing: World Industry and Market Outlook 2015-2025

/PRNewswire/ -- Report Details Contracted drug production - discover trends and segments with highest revenue potential Where's outsourced pharma manufacturing heading? Visiongain 's updated study predicts that industry's revenues from ...
 SearchBug1 month ago Generic Drugs Market Forecast 2015-2025 Opportunities For Leading Companies  Tamar Securities3 weeks ago
[x]  
Millennium Post

Swimming in a sea of sharks

It is perhaps only in India that Non-Performing Assets (NPAs) for government banks can reach an astronomical Rs 2,60,531 crores. So alarming is the situation that the Prime Minister's office (PMO) is supposedly going to announce strict punitive ...
 Millennium Post6 days ago
Zacks.com

The Parade of Weak Earnings Reports Continues - Earnings Preview

The flood of Q1 earnings announcements continues this week, with almost one thousand companies reporting results, including 159 S&P 500 members. By the end of this week, we will have seen Q1 results from 72% of the index's total membership. But ...
 Zacks.com1 week ago Revenue Weakness Stands Out in Q1 Earnings Season - Earnings Preview  Zacks.com2 weeks ago
Rediff.com

Should you buy mid-cap and small-cap stocks?

One needs to be cautious despite the uptick seen on Monday, as the real test of the rally in this segment will be the upcoming result season, analysts say Stocks from the mid-cap and small-cap segments have outperformed their larger peers in trade on Monday. Among individual stocks, Sharda Cropchem, Sterlite Technologies, KRBL, Asahi India Glass, HSIL, PTC India Financial Services, BEML, Oberoi Realty and The Ramco Cements gained between 4.7 per cent - 9.2 per cent among the mid-cap stocks. In ...
 Rediff.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less